The Innovation Corps (I-Corps™) program offers $50,000 grants for Faculty and Grad Student/Postdoc researchers to reduce the time and risk associated with translating technologies from lab to market, quickly assessing the market potential of inventions developed from fundamental discoveries in science and engineering. Teams work directly with leadership from the Southwest I-Corps Node (SWICORPS) at UT Austin to gain eligibility and prepare for the NSF grant program through regional activities.

The Corporate Relations team is uniquely suited to help connect UT's research and innovation with relevant and interested company partners. We seek to solicit and raise funding from companies to advance student programming, research and discovery. If UT students or faculty would like to explore developing/deepening ties with industry, we suggest that we first have an internal discussion to assess the opportunity so that we can make appropriate connections.

The Office of Industry Engagement (OIE) negotiates all contracts related to private industry research funding. OIE endeavors to streamline negotiations to better accommodate industry financial cycles and assist UT faculty in their collaborative efforts with industry partners. OIE focuses on flexible engagements and expedited contractual negotiations, through collaboration with internal and external stakeholders and with support from the Office of Technology Commercialization.

The Office of Sponsored Projects (OSP) provides support for all externally sponsored projects, excluding those sponsored by industry. Services include review/submission of proposals, negotiation/acceptance of awards, and setup of financial accounts. OSP also manages budget changes, financial reporting, invoicing, subrecipient monitoring, award extensions and audits. OSP has training available for managing awards as well as compliance with university and sponsor policies/regulations.

Pivot allows researchers in all disciplines to quickly discover funding opportunities that match their interests and expertise. Pivot is available to all UT faculty, staff researchers, research administrators and students.

For companies that have participated in our proposal preparation workshops and on-demand webinars, select 1:1 proposal preparation support may be available. Inquiries may be sent to Andrew Worden, Entrepreneurship Program Manager at Andrew.worden@austin.utexas.edu

Get help preparing your SBIR/STTR proposals. For UT Austin-affiliated startups preparing SBIR/STTR Phase I or Phase II proposals. Work with expert proposal preparers and ask questions specific to your proposal. Learn the details of agency-specific proposal preparation including electronic submission and commercialization plans. Agency-specific workshops for the National Science Foundation (NSF), Department of Defense (DOD), and National Institutes of Health (NIH) are offered periodically.

A 9-week summer accelerator program that picks the most promising emerging UT startups (undergrad, grad, and faculty teams) and helps them confront their next market-driven milestone. In its 13th year, alumni companies have collectively raised $100M and generated over $400M in valuation.

The Texas McCombs M.S. in Technology Commercialization (MSTC) program was the first ever go-to-market graduate program in the U.S. Designed as a launchpad for your businesses and products, MSTC gives you everything you need to take your ideas to market either through a venture of your own or an existing organization. A top-ranked, STEM-designated degree, MSTC remains one of the most popular and diverse programs for innovative working professionals who want to break into the market.

The Texas Global Health Security Innovation Consortium (TEXGHS) connects academic, public- and private-sector partners to support companies working towards pandemic preparedness and response in Texas. TEXGHS is developing a health security innovation ecosystem that supports innovators and innovations fighting COVID-19 and future pandemics. UT Austin entrepreneurs should contact TEXGHS when they are seeking to commercialize infectious disease-related innovations at any stage of development.